COVID-19
RAPID ANTIGEN TEST
Authorised for Self-Test and Professional Use in Singapore by the Health Sciences Authority (HSA) under the Pandemic Special Access Route (PSAR)
The INDICAID COVID-19 Rapid Antigen Test
Is a lateral flow immunoassay designed for the qualitative detection of SARS-CoV-2 antigens in direct nasal swab samples.
INDICAID was developed by PHASE SCIENTIFIC, a Hong Kong biotech company with support from the Bill & Melinda Gates Foundation, US National Institutes of Health (NIH) and US National Science Foundation (NSF).
INTENDED USE
-
Authorised for self-test use in Singapore by the Health Science Authority (HSA) under the Pandemic Special Access Route (PSAR).
-
Authorised for professional use in Singapore by the Health Science Authority (HSA) under the Pandemic Special Access Route (PSAR).
-
Ideal option for the rapid detection of SARS-CoV-2 infection in symptomatic or asymptomatic individuals suspected of infection or in close-contacts with individuals who are COVID-19 positive.
-
Can be used anywhere, anytime by anyone regardless of vaccination or symptom status.
PRODUCT ADVANTAGES
-
Accurate : Clinically validated with overall sensitivity and specificity at 91% and 96% respectively
-
Variants detectability : Able to detect the presence of certain COVID-19 variants, including Delta and Omicron variants.
-
Clinical Validation : tested in the world's largest clinical study with more than 23000 field samples.
-
Trusted brand : Widely adopted globally in hospitals, organizations, schools, restaurants, and retail stores
-
Market leader : The No.1 Rapid Test Kit in Hong Kong
INDICAID COVID-19 RAPID ANTIGEN TEST DEMO VIDEO
English Language
Cantonese Language
INSTRUCTION STEPS FOR USE
 |  |  |  |  |
|---|---|---|---|---|
 |  |
RESULT INTERPRETATION
